SCHEMBL30796360

SCHEMBL30796360

CC(C)(C)OC(=O)N1CCN(c2ccnc(-c3cc(-c4ccccc4O)cnc3N)c2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMARCA2 P51531 3/20 0.58
▸ SMARCA4 P51532 3/20 0.58
▸ PBRM1 Q86U86 2/20 0.58
▸ PIK3CA P42336 1/20 0.48
▸ PDK2 Q15119 1/20 0.44
▸ CKS1B P61024 2/20 0.43
▸ SKP1 P63208 2/20 0.43
▸ SKP2 Q13309 2/20 0.43
▸ PTPN11 Q06124 1/20 0.43
▸ RET P07949 1/20 0.42
▸ ATR Q13535 1/20 0.42
▸ KIT P10721 2/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ ALK Q9UM73 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ NAMPT P43490 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27461170 0.88 SMARCA2 (0.72) SMARCA2SMARCA4PBRM1PIK3CAPDK2
SCHEMBL30796629 0.88 SMARCA2 (0.72) SMARCA2SMARCA4PBRM1PIK3CAPDK2
SCHEMBL3268748 0.79 CKS1B (0.56) SMARCA2SMARCA4PBRM1PIK3CAPDK2
SCHEMBL27461169 0.78 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1PIK3CAPDK2
SCHEMBL30796853 0.78 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1PIK3CAPDK2
SCHEMBL27461283 0.78 SMARCA2 (0.57) SMARCA2SMARCA4PBRM1PIK3CAPDK2
SCHEMBL23630518 0.76 SMARCA2 (0.67) SMARCA2SMARCA4PBRM1PIK3CAPDK2
SCHEMBL29943871 0.76 SMARCA2 (0.67) SMARCA2SMARCA4PBRM1PIK3CAPDK2
SCHEMBL30520252 0.76 SMARCA2 (0.76) SMARCA2SMARCA4PBRM1PIK3CAPDK2
SCHEMBL25347040 0.76 SMARCA2 (0.76) SMARCA2SMARCA4PBRM1PIK3CAPDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4539849-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 Therapeutics, Inc. (US) 2025-04-23 — — EP disclosed
WO-2023244764-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 THERAPEUTICS, INC. (US) 2023-12-21 — — WO disclosed
Send feedback